14-3-3 is a class of proteins able to interact with a multitude of targets by establishing protein-protein interactions (PPIs). They are usually found in all eukaryotes with a conserved secondary structure and high sequence homology among species. 14-3-3 proteins are involved in many physiological and pathological cellular processes either by triggering or interfering with the activity of specific protein partners. In the last years, the scientific community has collected many evidences on the role played by seven human 14-3-3 isoforms in cancer or neurodegenerative diseases. Indeed, these proteins regulate the molecular mechanisms associated to these diseases by interacting with (i) oncogenic and (ii) pro-apoptotic proteins and (iii) with proteins involved in Parkinson and Alzheimer diseases. The discovery of small molecule modulators of 14-3-3 PPIs could facilitate complete understanding of the physiological role of these proteins, and might offer valuable therapeutic approaches for these critical pathological states.

Cau, Y., Valensin, D., Mori, M., Draghi, S., Botta, M. (2018). Structure, function, involvement in diseases and targeting of 14-3-3 proteins: An Update. CURRENT MEDICINAL CHEMISTRY, 25(1), 5-21 [10.2174/0929867324666170426095015].

Structure, function, involvement in diseases and targeting of 14-3-3 proteins: An Update

Cau, Ylenia;Valensin, Daniela;Mori, Mattia;Draghi, Sara;Botta, Maurizio
2018-01-01

Abstract

14-3-3 is a class of proteins able to interact with a multitude of targets by establishing protein-protein interactions (PPIs). They are usually found in all eukaryotes with a conserved secondary structure and high sequence homology among species. 14-3-3 proteins are involved in many physiological and pathological cellular processes either by triggering or interfering with the activity of specific protein partners. In the last years, the scientific community has collected many evidences on the role played by seven human 14-3-3 isoforms in cancer or neurodegenerative diseases. Indeed, these proteins regulate the molecular mechanisms associated to these diseases by interacting with (i) oncogenic and (ii) pro-apoptotic proteins and (iii) with proteins involved in Parkinson and Alzheimer diseases. The discovery of small molecule modulators of 14-3-3 PPIs could facilitate complete understanding of the physiological role of these proteins, and might offer valuable therapeutic approaches for these critical pathological states.
2018
Cau, Y., Valensin, D., Mori, M., Draghi, S., Botta, M. (2018). Structure, function, involvement in diseases and targeting of 14-3-3 proteins: An Update. CURRENT MEDICINAL CHEMISTRY, 25(1), 5-21 [10.2174/0929867324666170426095015].
File in questo prodotto:
File Dimensione Formato  
Structure-function-involvement-2018.pdf

non disponibili

Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 3.95 MB
Formato Adobe PDF
3.95 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Structure function involvement in diseases-Cau_et_al_CMC_PrePrint.pdf

accesso aperto

Descrizione: Submitted version
Tipologia: Pre-print
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 1.05 MB
Formato Adobe PDF
1.05 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1034658